Osteosarcoma is a bone cancer. It tends to happen most often in teenagers and young adults, but it can also happen in younger ...

OST-HER2 has received Rare Pediatric Disease Designation (RPDD) for osteosarcoma from the US FDA, and if it receives a conditional BLA via Accelerated Review prior to September 30, 2026 ...